Nanalysis Announces Grant of Stock Options

Rhea-AI Summary

Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) announced the granting of 2,237,000 stock options. Of these, 1,035,000 options were awarded to directors and officers, while 1,202,000 options were given to employees and advisors. Each option permits the purchase of one common share at $0.50 per share, with a five-year exercise window from issuance. Vesting periods range from immediate to three years.

Positive

• The issuance of 2,237,000 stock options provides potential long-term incentives for directors, officers, employees, and advisors.
• Options are exercisable at $0.50 per share, potentially benefiting recipients if the market price increases.
• Vesting periods varying from immediate to three years may enhance employee retention and motivation.

Negative

• The grant of a large number of stock options (2,237,000) may lead to shareholder dilution.
• Potential overhang on the stock price if a significant number of options are exercised at once.

CALGARY, AB, June 7, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), announces that the Company's Board of Directors has granted a 1,035,000 stock options (the "Options") to its directors and officers, as well as an additional 1,202,000 Options to employees and advisors, pursuant to the Company's stock option plan. Each Option is exercisable to purchase one common share in the capital of the Company at $0.50 per share for a period of five years from the date of issuance.  Vesting occurs over periods ranging from immediate to three years.

About Nanalysis Scientific Corp. (TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)

Nanalysis Scientific Corp. in operates two primary business segments: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms "MRI and NMR for industry". The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz device, the most powerful and most advanced compact NMR device ever brought to market. 

The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company continues to exploit new global market opportunities independently and with partners.  With its partners, the Company provides scientific equipment sales and maintenance services globally. 

In 2022 the Company was awarded a five-year, $160 million contract to provide maintenance services for passenger screening equipment in Canadian airports.  This has resulted in expansion of the Company's Security Services business.  The Company is providing airport security equipment maintenance services in each province and territory of Canada.  In addition, the Company provides commercial security equipment installation and maintenance services to a variety of customers in North America. 

Notice regarding Forward Looking Statements and Legal Disclaimer

This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nanalysis-announces-grant-of-stock-options-302167209.html

SOURCE Nanalysis Scientific Corp.

FAQ

What did Nanalysis Scientific Corp. announce on June 7, 2024?

Nanalysis announced the granting of 2,237,000 stock options to its directors, officers, employees, and advisors.

How many stock options were granted to directors and officers by Nanalysis?

1,035,000 stock options were granted to directors and officers.

How many stock options did Nanalysis grant to employees and advisors?

1,202,000 stock options were granted to employees and advisors.

At what price can the granted stock options be exercised?

The stock options can be exercised at $0.50 per share.

What is the duration for exercising the stock options granted by Nanalysis?

The stock options can be exercised over a period of five years from the date of issuance.

What are the vesting periods for the stock options granted by Nanalysis?

The vesting periods for the stock options range from immediate to three years.